First-in-human evaluation of a sirolimus-eluting coronary stent on an integrated delivery system: the DIRECT study

Abstract

Percutaneous coronary intervention using the Svelte sirolimus-eluting coronary stent mounted on an IDS appears safe and effective in de novo coronary artery lesions, with minimal in-stent proliferation and excellent stent strut coverage at six months.